Literature DB >> 20888658

Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis.

Karin D Hove1, Kristine Færch, Thóra B Bödvarsdóttir, Allan E Karlsen, Jacob S Petersen, Allan Vaag.   

Abstract

We retrospectively studied whether treatment with esomeprazole improved HbA₁(c) levels in type 2 diabetic patients. We selected 21 patients who had been treated with esomeprazole for 11 ± 3 months and 21 controls. HbA₁(c) levels decreased in the esomeprazole-treated group. Our data indicate that proton pump inhibitors may improve glycaemic control in type 2 diabetic patients.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20888658     DOI： 10.1016/j.diabres.2010.09.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  13 in total

Review 1.  Combination immunotherapies for type 1 diabetes mellitus.

Authors:  Paolo Pozzilli; Ernesto Maddaloni; Raffaella Buzzetti
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

2.  Regulation of adipocyte differentiation and metabolism by lansoprazole.

Authors:  Ameena Benchamana; Hiroyuki Mori; Ormond A MacDougald; Sunhapas Soodvilai
Journal:  Life Sci       Date:  2019-10-20       Impact factor: 5.037

3.  Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background.

Authors:  Milena Saqui-Salces; Amy C Tsao; Merritt G Gillilland; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-03       Impact factor: 4.052

4.  Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.

Authors:  K D Hove; C Brøns; K Færch; S S Lund; J S Petersen; A E Karlsen; P Rossing; J F Rehfeld; A Vaag
Journal:  Diabetologia       Date:  2012-09-26       Impact factor: 10.122

5.  Are proton pump inhibitors a new antidiabetic drug? A cross sectional study.

Authors:  Diana Boj-Carceller; Pilar Bocos-Terraz; Miguel Moreno-Vernis; Alejandro Sanz-Paris; Pablo Trincado-Aznar; Ramón Albero-Gamboa
Journal:  World J Diabetes       Date:  2011-12-15

6.  Effect of proton pump inhibitors on glycemic control in patients with diabetes.

Authors:  Kohzo Takebayashi; Toshihiko Inukai
Journal:  World J Diabetes       Date:  2015-08-25

Review 7.  Proton pump inhibitors: impact on glucose metabolism.

Authors:  Diana Boj-Carceller
Journal:  Endocrine       Date:  2012-08-12       Impact factor: 3.633

8.  The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats.

Authors:  Eivind Grong; Ingerid Brænne Arbo; Ole Kristian Forstrønen Thu; Esther Kuhry; Bård Kulseng; Ronald Mårvik
Journal:  Surg Endosc       Date:  2014-08-09       Impact factor: 4.584

9.  Impact of drugs on hypoglycaemia in hospitalised patients.

Authors:  Frederik Vandenberghe; Corinne Challet; Mathias Maitrejean; Laurent Christin; Nicolas Schaad
Journal:  Eur J Hosp Pharm       Date:  2018-03-17

10.  Improved diabetes control and pancreatic function in a type 2 diabetic after omeprazole administration.

Authors:  I N Mefford; J T Mefford; C A Burris
Journal:  Case Rep Endocrinol       Date:  2012-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.